Sodium‐glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a meta‐analysis
Abstract Aims Sodium‐glucose cotransporter 2 (SGLT2) inhibitors have been shown to be an effective therapy in improving heart failure outcomes. We conducted a meta‐analysis of randomized controlled trials to evaluate the efficacy of SGLT2 inhibitors in heart failure patients with either a reduced or...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2022-04-01
|
| Colección: | ESC Heart Failure |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1002/ehf2.13805 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|